《MedRxiv,4月3日,Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-05
  • Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US

    View ORCID ProfileSlav W Hermanowicz

    doi: https://doi.org/10.1101/2020.03.31.20049486

    This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

    Abstract

    In our previous work, we analyze, in near-real time, evolution of Covid-19 epidemic in China for the first 22 days of reliable data (up to February 6, 2020). In this work, we used the data for the whole 87 days (up to March 13, 2020) in China and the US data available till March 31 (day 70) for systematic evaluation of the logistic model to predict epidemic growth. We sequentially estimated sets of model parameters (maximum number of cases K, growth rate r, and half-time t0) and the epidemic "end time" t95 (defined as the time when the number of cases, predicted or actual, reached 95% of the maximum). The estimates of these parameters were done for sequences of reported cases growing daily (back-casting for China and forecasting for the US). In both countries, the estimates of K grew very much in time during the exponential and nearly exponential phases making longer term forecasting not reliable. For the US, the current estimate of the maximum number of cases K is about 265,000 but it is very likely that it will grow in the future. However, running estimates of the "end time" t95 were in a much smaller interval for China (60 - 70 days vs. the actual value of 67). For the US, the values estimated from the data sequences going back two weeks from now range from 70 to 80 days. If the behavior of the US epidemic is similar to the previous Chinese development, the number of reported cases could reach a maximum around April 10 to 14.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.03.31.20049486v1
相关报告
  • 《MedRxiv,3月16日,Rational evaluation of various epidemic models based on the COVID-19 data of China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-17
    • Rational evaluation of various epidemic models based on the COVID-19 data of China Wuyue Yang, Dongyan Zhang, Liangrong Peng, Changjing Zhuge, Liu Hong doi: https://doi.org/10.1101/2020.03.12.20034595 Abstract During the study of epidemics, one of the most significant and also challenging problems is to forecast the future trends, on which all follow-up actions of individuals and governments heavily rely. However, to pick out a reliable predictable model/method is far from simple, a rational evaluation of various possible choices is eagerly needed, especially under the severe threat of COVID-19 epidemics which is spreading worldwide right now. In this paper, based on the public COVID-19 data of seven provinces/cities in China reported during the spring of 2020, we make a systematical investigation on the forecast ability of eight widely used empirical functions, four statistical inference methods and five dynamical models widely used in the literature. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《4月3日_利用简单模型对中国COVID-19进行回推以及对美国进行预测》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-06
    • 1.时间:2020年4月3日 2.机构或团队:美国加州大学伯克利分校 3.事件概要: 美国加州大学伯克利分校的研究人员在medRxiv预印版平台发表论文“Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US”。文章中,研究人员使用了中国截至2020年3月13日的87天数据和美国截至3月31日的70天数据,对Logistic模型进行系统评估以预测疫情的增长。依次估算了模型参数集(最大病例数K,增长率r和中间时间t0)和疫情“结束时间” t95(定义为预测或实际病例数达到最大值的95%的时间)。这些参数的估计是针对每日增长的报告病例序列进行的(对中国进行回推,对美国进行预测) 该研究分析结果显示,在这两个国家中,K的估计值在指数和接近指数阶段随时间增长很大,这使得长期预报不可靠。对于美国来说,目前对最大病例数K的估计约为265,000例,但很有可能会在未来增长。但是,对中国来说,“结束时间” t95的运行估算值要短得多(60-70天,而实际值为67)。对于美国,从现在起两周前的数据序列中估算的值范围为70到80天。文章指出如果美国疫情的变化与中国以往的发展相似,则报告的病例数可能在4月10日至14日左右达到最大值。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用。 4.附件: 原文链接:https://www.medrxiv.org/content/10.1101/2020.03.31.20049486v1.article-info